News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Earnings (World)
China Biologic Products Reports Financial Results For The Fourth Quarter And Fiscal Year 2014 3/5/2015
Siegfried Release: Annual Report 2014 3/5/2015
Cellectis (ALCLS): 2014 Financial Results 3/5/2015
2014: A Year Of Technical Achievements And Organizational Structure, Accelerating Carbios' Pre-Industrial Development 3/5/2015
Aptose Biosciences Reports Results For The Quarter And Seven Months Ended December 31, 2014 3/4/2015
Newron Pharmaceuticals (NWRN) Reports 2014 Financial Results 3/4/2015
Clinigen Group Plc Release: Half Year Revenues Up 17% To £72.6m, Underlying EBITDA Up 8% To £13.5m 3/3/2015
Ipsen (IPN.PA)’s 2014 Results and 2015 Financial Objectives 3/3/2015
Second Quarter Results - Fiscal 2015 - Ergoresearch Inc. (ERG) Reports Its Results For The Quarter Ended December 31, 2014 3/2/2015
Endo International (ENDP) Reports Fourth Quarter And Full Year 2014 Financial Results 3/2/2015
Allergy Therapeutics plc Release: Interim Report For The Six Months Ended 31 December 2014 3/2/2015
Antibe Therapeutics Inc. (ATE.V) Reports Q3 2015 Interim Financial And Operating Results And Director Resignation 3/2/2015
Horizon Pharma plc.  (HZNP) Announces Fourth Quarter And Full Year 2014 Financial Results And Raises Guidance For 2015 3/2/2015
Neovacs SA: Financial Results For 2014 2/27/2015
Moberg Pharma AB (Formerly known as Moberg Derma) Year-end Report 2014 2/27/2015
Medivir AB (MVRBF): Financial Statement, January – December 2014 2/27/2015
China Cord Blood Corporation Reports Financial Results For The Third Quarter And First Nine Months Of Fiscal 2015 2/26/2015
ProQR Therapeutics B.V. (PRQR) Announces Results For The Fourth Quarter And Full Year 2014 2/26/2015
RedHill Biopharma Ltd. (RDHL) Reports 2014 Fourth Quarter And Year-End Financial Results 2/26/2015
Evogene Ltd. (EVGN) Reports Fourth Quarter And Full Year 2014 Financial Results 2/26/2015
Circassia Pharmaceuticals Plc Preliminary Results For The Year Ended 31 December 2014 2/26/2015
Ablynx (ABLYF) Announces 2014 Full Year Results 2/26/2015
Macrocure (MCUR) Announces Fourth Quarter And Full Year 2014 Financial Results Date And Conference Call 2/25/2015
Jazz Pharmaceuticals (JAZZ) Announces Full Year And Fourth Quarter 2014 Financial Results 2/25/2015
Cipher Pharmaceuticals (DND.TO) Reports Financial Results For Fiscal 2014 2/25/2015
ICON Reports Fourth Quarter And Full Year 2014 Results And Issues 2015 Earnings Guidance 2/25/2015
Alkermes plc (ALKS) Reports Financial Results For The Year Ended Dec. 31, 2014 And Provides Financial Expectations For 2015 2/24/2015
Valeant (VRX) Reports Fourth Quarter And Full Year 2014 Financial Results 2/23/2015
Nordic Nanovector – Fourth Quarter Report 2014 2/23/2015
Nordic Nanovector – Fourth Quarter Report 2014 2/23/2015
Aerocrine Achieves Record Sales For The 4th Quarter And Full Year 2/20/2015
Ablynx (ABLYF) Will Announce Its Full Year Results 2014 With Webcast 2/19/2015
Innate Pharma (IPH.PA ) : Annual Results 2014: Stronger Cash Position And Expanded Clinical Portfolio 2/19/2015
Regeneus (RGS.AX) Half-Yearly Report and Accounts 2/19/2015
Reproductive Health Science Ltd (Asx:Rhs) Appendix 4e Financial Report 2/19/2015
Oxford Immunotec Limited (OXFD) Schedules Fourth Quarter And Full Year 2014 Earnings Release And Conference Call For March 3, 2015 2/19/2015
Swedish Orphan AB Publishes Its Report For The Fourth Quarter And Full Year 2014 2/19/2015
Enzymotec Reports Fourth Quarter And Full Year 2014 Unaudited Financial Results 2/18/2015
Actavis (ACT) Non-GAAP Net Revenue Increases 44% To $4 Billion In Fourth Quarter 2014; Non-GAAP EPS Increases 23% To $3.91; Increases 2015 Standalone Forecast 2/18/2015
Nanosonics Reports Half Year Financial Results 2/18/2015
Alkermes plc (ALKS) To Host Conference Call To Discuss Fourth Quarter And Year-End 2014 Financial Results 2/18/2015
BioInvent (BOVNF) Financial Statement 1 January – 31 December 2014 2/18/2015
NeuroVive Pharmaceutical AB: Year-End Report 1 Jan. 2014 Till 31 Dec. 2014 2/18/2015
BioBlast Pharma (ORPN) Reports Fourth Quarter Financial Results 2/17/2015
China Biologic Products To Report Fourth Quarter And Fiscal Year 2014 Financial Results 2/17/2015
Adocia: Annual Revenue And Net Cash Position For 2014 2/17/2015
Invitation To Presentation Of Recipharm AB’s Full-Year-Report For 2014 On 19 February 2015 2/16/2015
WuXi PharmaTech Co., Ltd. Schedules Fourth-Quarter 2014 Earnings Release 2/13/2015
Endo Pharmaceuticals (ENDP) To Announce Fourth Quarter 2014 Financial Results On March 2, 2015 2/13/2015
Karo Bio AB: Year-End Report 2014 2/13/2015
Alcobra (ADHD) Announces Fourth Quarter And Fiscal Year 2014 Financial Results And Provides Corporate Update 2/12/2015
Biotage: Year-End Report For 2014 2/12/2015
Sangui BioTech International Inc. (SGBI): Revenues Slightly Improved In The First Half Of The 2015 Financial Year 2/12/2015
RaySearch Laboratories Year-End Report 2014 2/12/2015
Shire (SHPGY) Delivers Record Revenues And Non GAAP Earnings Per ADS In 2014, And Enters 2015 With Strongest-Ever Pipeline 2/12/2015
Synutra Reports Third Quarter And First Nine Months Of Fiscal 2015 Financial Results 2/10/2015
IXICO Release: Financial Results For The Sixteen Month Period Ended 30 September 2014 2/10/2015
Compugen Ltd. (CGEN) Reports Fourth Quarter And Calendar 2014 Results 2/10/2015
Psychemedics Corporation (PMD) Announces Record Revenues 2/10/2015
Ossur (OSSR) - Q4&FY Results 2014 2/6/2015
MediWound (MDWD) To Host Fourth Quarter And Year End 2014 Financial Results Conference Call On February 12, 2015 At 8:30 A.M. Eastern Time 2/6/2015
Origin Agritech Limited (SEED) Reports Unaudited Financial Results For Three Months Ended December 31, 2014 And Announces Its First United States Patent Application 2/5/2015
Perrigo Company plc Reports Record Second Quarter Revenue, Adjusted Net Income And Adjusted Margins 2/5/2015
BTG plc (BTG.L) Updates Revenue Guidance And Ceases Publication Of Interim Management Statements 2/5/2015
Teva Pharmaceutical Industries Limited (TEVA) Reports Fourth Quarter And Full Year 2014 Results 2/5/2015
Enzymotec To Report Fourth Quarter And Full Year 2014 Financial Results 2/4/2015
ScinoPharm Reports Financial Performance For 2014 2/3/2015
Mallinckrodt plc Reports Fiscal 2015 First Quarter Financial Results 2/3/2015
Ipsen (IPN.PA): Sales In The Fourth Quarter And Full Year 2014 2/3/2015
Alcobra (ADHD) To Release Fourth Quarter And Fiscal Year 2014 Financial Results And Host Corporate Update Conference Call & Webcast On February 12 2/2/2015
Neuland Labs Reports Third Quarter Fiscal Year 2015 Financial Results 1/30/2015
Dr. Reddy's Laboratories, Inc. (RDY)'s Q3 And 9 Months FY15 Financial Results 1/29/2015
Orexo AB (ORXOF): Full Year Report January-December 2014 1/29/2015
SanguiBioTech GmbH Yields Revenues Of Over USD31,000 In Q2 2015 According To Preliminary Figures 1/28/2015
CBI Pharma To Hold 6th Annual IVD Summit 2015 On March 12-13 In Shenzhen, China 1/27/2015
Successful Business Year 2014: Sartorius Achieves Sales And Earnings Targets – Positive Outlook For 2015 1/27/2015
Perrigo Company plc To Release Second Quarter Fiscal Year 2015 Results On February 5, 2015 1/22/2015
Medivir AB (MVRBF): OLYSIO® Sales During The Fourth Quarter 2014 1/20/2015
Teva Pharmaceutical Industries Limited (TEVA) To Report Fourth Quarter 2014 Financial Results On February 5, 2015 1/16/2015
Actavis (ACT) Announces Exceptional Preliminary Fourth Quarter 2014 Performance 1/12/2015
Mallinckrodt Pharmaceuticals (MNK) To Report First Quarter Fiscal 2015 Results On February 3, 2015 1/6/2015
Tianyin Pharmaceutical Co, Inc. Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 12/29/2014
NeuroDerm Ltd. (NDRM) Announces Third Quarter 2014 Financial Results And Provides A Corporate Update 12/18/2014
Origin Agritech Limited (SEED) To Announce Fiscal 2014 Annual Financial Results On January 8th, 2015 12/15/2014
Abzena PLC Release: Interim Results For The Six Months Ended 30 September 2014 12/11/2014
Tianyin Pharmaceutical Co, Inc. Reports Fiscal Year 2014 Financial Results 12/11/2014
Scancell Holdings Plc Interim Results For The Six Months Ended 31 October 2014 12/10/2014
Consort Medical Interim Results For The Six Months Ended 31 October 2014 12/4/2014
GW Pharmaceuticals plc Reports 2014 Q4 And Full Year Financial Results 12/2/2014
uniQure Announces Results For The Third Quarter Of 2014 12/1/2014
iCo Therapeutics Inc. Announces Third Quarter 2014 Financial Results And Corporate Update 12/1/2014
Antibe Therapeutics Inc. Reports Q2 2015 Interim Financial And Operating Results 12/1/2014
XTL Biopharmaceuticals Ltd. (XTLB) Provides Financial and Operational Update For the Third Quarter of 2014 12/1/2014
China Cord Blood Corporation Reports Financial Results For The Second Quarter And First Half Of Fiscal 2015 11/26/2014
ProQR Therapeutics B.V. (PRQR) Announces Results For The Third Quarter Of 2014 11/24/2014
Bio Blast Pharma Reports Third Quarter Financial Results 11/21/2014
Medivir AB (MVRBF): Interim Report, January – September 2014 11/20/2014
Mallinckrodt plc Reports Fiscal 2014 Fourth Quarter And Fiscal 2014 Financial Results 11/19/2014
China Cord Blood Corporation To Report Second Quarter And First Half Of Fiscal 2015 Financial Results 11/18/2014
Affimed Reports Financial Results For Third Quarter 2014 11/18/2014
Cardio3 BioSciences Announces Q3 2014 Business Update 11/18/2014
ConvaTec Announces 2014 Third Quarter Earnings Call 11/17/2014
Sinovac Biotech Ltd. (SVA) Reports Unaudited Third Quarter Financial Results 11/17/2014
ProSensa Holding N.V. (RNA) Announces 3rd Quarter 2014 Financial Results And Recent Corporate Developments 11/17/2014
WuXi PharmaTech Co., Ltd. Reports Record Revenues, CapEx Spending 11/17/2014
Foamix Pharmaceuticals, Ltd. (FOMX) Reports Financial Results For Third Quarter And Nine Months Ended September 30, 2014 11/14/2014
China Pharma Holdings, Inc. (CPHI.OB) Reports Third Quarter 2014 Financial Results 11/14/2014
Biostar Pharmaceuticals, Inc. (BSPM) Announces Third Quarter 2014 Financial Results 11/14/2014
ALK-Abello A/S Release: Nine-Month Interim Report (Q3) 2014 11/14/2014
Moberg Pharma AB (Formerly known as Moberg Derma) Interim Report January – September 2014 11/14/2014
WuXi PharmaTech Co., Ltd. Announces Third-Quarter 2014 Results 11/13/2014
BrainStorm Cell Therapeutics Inc. Announces Financial Results For The Third Quarter Of 2014 And Provides Corporate Update 11/13/2014
Ablynx (ABLYF) Announces Its Business Update For The First Nine Months Of 2014 11/13/2014
Enzymotec Reports Third Quarter 2014 Unaudited Financial Results 11/13/2014
Innocoll, Inc. (INNL) Announces Third Quarter 2014 Financial and Operating Results 11/13/2014
Sophiris Bio Inc. (SPHS) Reports Third Quarter Financial Results 11/13/2014
Sangui BioTech International Inc. (SGBI): Revenues Improved In The First Quarter Of The 2015 Financial Year 11/13/2014
Galmed Pharmaceuticals Provides Business Update And Reports Year-To-Date 2014 Financial Results 11/12/2014
Evotec AG (EVTG.F) Reports Results Of The First Nine Months Of 2014 11/12/2014
Kamada Ltd. (KMDA) Announces Third Quarter 2014 Financial Results 11/12/2014
Veloxis Pharmaceuticals A/S (VELO) Announces Financial Results For The First Nine Months Of 2014 And Improves The Full Year Outlook 11/12/2014
Affimed Therapeutics AG (AFMD) Announces Third Quarter 2014 Financial Results Conference Call 11/11/2014
SYGNIS Reports Nine-Month Results For The Period Ended 30 September 2014 And Announces New Product And Commercialisation Strategy 11/11/2014
Release Date Of Nine-Month Interim Report (Q3) 2014 For ALK-Abello A/S 11/10/2014
RedHill Biopharma Ltd. (RDHL) Reports Results For The Third Quarter Of 2014 11/10/2014
Foamix Pharmaceuticals, Ltd. (FOMX) Third Quarter 2014 Conference Call & Webcast Scheduled For Monday, November 17, 2014 11/10/2014
BioLineRx Ltd. Reports Third Quarter 2014 Financial Results 11/10/2014
Kamada Ltd. (KMDA) To Host Third Quarter 2014 Financial Results Conference Call On November 12, 2014 11/10/2014
Cardiome Pharma Corp. (COM.TO) Reports Third Quarter 2014 Financial Results 11/7/2014
Innocoll, Inc. (INNL) To Report Third Quarter 2014 Financial Results And Host Webcast And Conference Call On November 13, 2014 11/7/2014
Recipharm AB: Interim Report January-September 2014 11/7/2014
Horizon Pharma plc.  (HZNP) Reports Third Quarter 2014 Financial Results And Raises Guidance For 2014 And 2015 11/7/2014
China Biologic Products Reports Financial Results For The Third Quarter And First Nine Months Of 2014 11/6/2014
Oncolytics Biotech Inc. (ONC.TO) Announces Third Quarter 2014 Results 11/6/2014
BRASKEM Announces 3Q14 Results 11/6/2014
MediWound (MDWD) Reports Third Quarter 2014 Financial Results 11/6/2014
MEDA: Interim Report, January-September 2014 11/6/2014
PhotoCure: Results For Third Quarter And The First Nine Months 2014 11/6/2014
Hikma Pharmaceuticals (HIK.L) Release: Interim Management Statement 11/6/2014
Alcobra (ADHD) To Release Third Quarter 2014 Financial Results And Host Corporate Update Conference Call And Webcast On Monday, November 17 11/6/2014
Onxeo: Quarterly Information As Of September 30, 2014 11/6/2014
Jazz Pharmaceuticals plc (JAZZ) Announces Third Quarter 2014 Financial Results And Updated Guidance 11/5/2014
AEterna Zentaris (AEZS) Reports Third Quarter 2014 Financial And Operating Results 11/5/2014
Evotec AG (EVTG.F) To Report Results For The First Nine Months Of 2014 On 12 November 2014 11/5/2014
Sinovac Biotech Ltd. (SVA) To Host Conference Call To Report Third Quarter 2014 Unaudited Financial Results 11/5/2014
Actavis (ACT) Net Revenue Increases 83% To $3.7 Billion In Third Quarter 2014; Non-GAAP EPS Increases 53% To $3.19 11/5/2014
Endo Pharmaceuticals (ENDP) Reports Third Quarter Financial Results 11/5/2014
China Pharma Holdings, Inc. (CPHI.OB) To Hold Third Quarter 2014 Earnings Conference Call On Friday November 14, 2014 At 8:30 A.M. ET 11/5/2014
BrainStorm Cell Therapeutics Inc. To Report Third Quarter 2014 Financial Results On Thursday, November 13 11/5/2014
Foundation Medicine, Inc. (FMI) Announces 2014 Third Quarter Results and Recent Highlights 11/5/2014
Macrocure (MCUR) Announces Third Quarter 2014 Financial Results 11/4/2014
Prothena Corporation plc Reports Third Quarter 2014 Financial Results And R&D Progress 11/4/2014
Resverlogix Corporation (RVX.TO) Names Michael Sweeney, M.D., As Senior Vice President Of Clinical Development 11/4/2014
TxCell Reports Revenues For The Third Quarter Of 2014 11/4/2014
BioLineRx Ltd. To Report Third Quarter 2014 Results On November 10, 2014 11/3/2014
BioTie Therapies Corp. Interim Report 1 January - 30 September 2014 10/31/2014
Lonza Group Ltd. (LZAGY.PK)’s Overall Business Performance Year-to-Date On Track 10/31/2014
Enzymotec To Report Third Quarter Fiscal Year 2014 Financial Results 10/30/2014
China Biologic Products To Report Third Quarter 2014 Financial Results 10/30/2014
Aptose Biosciences To Host Conference Call And Webcast For Four Month Interim Period Ended September 30, 2014 10/30/2014
Biotage AB (BIOTa.ST): Interim Report For The Period January - September 2014 10/30/2014
Teva Pharmaceutical Industries Limited (TEVA) Reports Third Quarter 2014 Results 10/30/2014
PHT Corporation Achieves Strong Growth In 3rd Quarter As Demand For Patient-Driven eData Systems In Clinical Research Grows 10/30/2014
Beximco Pharmaceuticals Release: Financial Results For The Third Quarter Of 2014 10/30/2014
Swedish Orphan Biovitrum Publishes Report For The Third Quarter 2014 10/30/2014
Pharming Group (PHGUF.PK) Reports On Financial Results For The First Nine Months Of 2014 10/30/2014
Neuland Labs Reports Second Quarter Fiscal Year 2015 Financial Results 10/29/2014
Ipsen (IPN.PA): Sales In The 3rd Quarter And First Nine Months Of 2014 10/29/2014
TRANSGENE (ENX:TNG) Announces Events Calendar For Fourth Quarter 2014 10/29/2014
Alkermes plc (ALKS) Reports Third Quarter 2014 Financial Results 10/29/2014
MediWound (MDWD) To Host Third Quarter 2014 Financial Results Conference Call On November 5, 2014 At 4:30 P.M. Eastern Time 10/29/2014
Compugen Ltd. (CGEN) Reports Third Quarter 2014 Financial Results 10/29/2014
Karo Bio AB: Interim Report January-September 2014 10/29/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Q2 And H1 FY15 Financial Results 10/29/2014
AEterna Zentaris (AEZS) To Announce Third Quarter 2014 Financial And Operating Results On November 4, 2014 10/28/2014
IMRIS Reports Third-Quarter 2014 Financial Results 10/28/2014
Sanofi (SAN.PA) Q3 2014 Results - Interview With Jérôme Contamine 10/28/2014
Nolato: Strong Earnings And High Margin 10/28/2014
Oxford Immunotec Limited (OXFD) Schedules Third Quarter 2014 Earnings Release and Conference Call For November 4, 2014 10/24/2014
Shire’s Clear And Focused Strategy Delivers Record Quarterly Revenues. Non GAAP Diluted Earnings Per ADS Up 60%. 10/24/2014
Perrigo Company (PRGO) To Release First Quarter Fiscal Year 2015 Results On November 6, 2014 10/23/2014
Flamel Technologies (FLML) To Report Third Quarter Of Fiscal Year 2014 Results 10/23/2014
Alkermes plc (ALKS) To Host Conference Call To Discuss Third Quarter 2014 Financial Results 10/23/2014
BioInvent (BOVNF) Interim Report 1 January – 30 September 2014 10/23/2014
Novozymes A/S (NVZMY) Increases Expectations For Full-Year Profit After Strong Q3 10/23/2014
Trinity Biotech (TRIB) Temporary Suspends Meritas Troponin Trials 10/23/2014
ICON Reports Third Quarter 2014 And Increases Earnings Guidance 10/22/2014
Macrocure (MCUR) Announces Third Quarter 2014 Financial Results Date And Conference Call 10/21/2014
WuXi PharmaTech Co., Ltd. Schedules Third-Quarter 2014 Earnings Release 10/21/2014
CARMAT: 2014 Half-Year Results 10/21/2014
Karolinska Development AB (publ) – Interim Report January – September 2014 10/21/2014
Dr. Reddy's Laboratories Ltd. (RDY)'s to Release Q2 FY15 Results On October 29, 2014 10/17/2014
Getinge Group Interim Report January – September 2014 10/16/2014
Medgenics, Inc. Reports Positive Initial Clinical Data And Third Quarter Financial Results 10/15/2014
Mallinckrodt plc Provides Fiscal Year 2015 Financial Guidance 10/14/2014
Acasti Pharma Announces Second Quarter Results 10/14/2014
MEDIAN Technologies Release: 2014 First Half Results In Line With Expectations 10/9/2014
Gerresheimer Increases Third-Quarter Revenues 10/8/2014
Teva Pharmaceutical Industries Limited (TEVA) To Report Third Quarter 2014 Financial Results On October 30, 2014 10/7/2014
Sangui BioTech International Inc. (SGBI) Yields Revenues Of Over USD70,000 In Q1 2015 According To Preliminary Figures 10/7/2014



//-->